Lo Biosciences, Inc.

North Bethesda, MD

UEI
JPVWZEYKLXN3
CAGE
875Y7
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Subcontinent Asian (Asian-Indian) American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
12358 Parklawn Dr #280, North Bethesda, MD 20852, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

About Lo Biosciences, Inc.

Lo Biosciences, Inc. is a minority-owned, for-profit biotechnology company based in Rockville, MD, specializing in diagnostic technologies and point-of-care testing solutions for infectious diseases. The company focuses on developing innovative diagnostic devices and technologies that enable more accessible and efficient medical testing, particularly for challenging infectious diseases like HIV and hepatitis C. Registered in SAM.gov since October 2018, Lo Biosciences, Inc. has demonstrated a strategic approach to developing advanced medical diagnostic solutions that address critical public health challenges.

The company has secured federal grant awards primarily from the Centers for Disease Control and Prevention (CDC) and the National Science Foundation (NSF), focusing on developing advanced blood separation and diagnostic testing technologies. Its most recent significant award is a $994,658 project grant from the CDC's Investigations and Technical Assistance program, aimed at creating a novel remote blood separation device for at-home plasma collection to enable HIV-1 testing. Previously, Lo Biosciences, Inc. was involved in a cooperative agreement with the NSF's Technology, Innovation, and Partnerships program to develop blood-plasma separation technologies for point-of-care diagnostic testing. The company's work consistently demonstrates a commitment to creating low-cost, efficient systems for robust diagnostic testing, with a particular emphasis on improving detection methods for infectious diseases like HIV and hepatitis C. Their technological innovations seek to overcome current limitations in blood testing by developing alternative sample collection and processing methods that can be used in diverse clinical settings.

Quick answers

What is Lo Biosciences, Inc.'s UEI?

Lo Biosciences, Inc.'s Unique Entity ID (UEI) in SAM.gov is JPVWZEYKLXN3.

What is Lo Biosciences, Inc.'s CAGE code?

Lo Biosciences, Inc.'s CAGE code is 875Y7.

What is Lo Biosciences, Inc.'s primary NAICS code?

Lo Biosciences, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Lo Biosciences, Inc. located?

Lo Biosciences, Inc.'s physical address in SAM.gov is 12358 Parklawn Dr #280, North Bethesda, MD 20852, USA.

Is Lo Biosciences, Inc. registered in SAM.gov?

Yes. Lo Biosciences, Inc.'s SAM.gov registration is active through July 26, 2027.

What is Lo Biosciences, Inc.'s most recent federal award?

Lo Biosciences, Inc.'s most recent federal grant award is A novel remote blood separation device for at-home plasma collection for HIV-1 testing (R44PS005271), from Office of Financial Resources, on September 30, 2025.

On GovTribe

See Lo Biosciences, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors